Xtalks Announces its Life Science Webinar Calendar for February 2026
Upcoming free, educational webinars from Xtalks will feature topics biomarkers, cell and gene therapy, clinical trials, drug discovery & development, pharmacovigilance and pharma manufacturing & supply chain.
Visit www.xtalks.com to see our upcoming webinars:
BIOMARKERS
CELL AND
CLINICAL TRIALS
DRUG DISCOVERY & DEVELOPMENT
PHARMACOVIGILANCE
PHARMA MANUFACTURING & SUPPLY CHAIN
ABOUT XTALKS
Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Tel: +1 (416) 977-6555 x272
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtalks-announces-its-life-science-webinar-calendar-for-february-2026-302676030.html
SOURCE Xtalks
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JCET Reports 79.4% YoY Growth in H1 2026 Net Profit Attributable to Shareholders, Accelerates Advanced Packaging Expansion
- Chris Hansen Releases "Sextortion: A Chris Hansen Investigation," a Documentary Special on the Child Sextortion Crisis -- Free to Distribute and Free to Watch
- inFlow Inventory launches lot number and expiry date tracking
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share